Intervention Review

Drug therapy for chronic idiopathic axonal polyneuropathy

  1. Alexander FJE Vrancken1,*,
  2. Ivo N van Schaik2,
  3. Richard AC Hughes3,
  4. Nicolette C Notermans1

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 19 APR 2004

Assessed as up-to-date: 15 FEB 2011

DOI: 10.1002/14651858.CD003456.pub2

How to Cite

Vrancken AFJE, van Schaik IN, Hughes RAC, Notermans NC. Drug therapy for chronic idiopathic axonal polyneuropathy. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003456. DOI: 10.1002/14651858.CD003456.pub2.

Author Information

  1. 1

    University Medical Center Utrecht, Department of Neurology, Utrecht, Netherlands

  2. 2

    Academic Medical Centre, University of Amsterdam, Department of Neurology, Amsterdam, Netherlands

  3. 3

    National Hospital for Neurology and Neurosurgery, MRC Centre for Neuromuscular Diseases, London, UK

*Alexander FJE Vrancken, Department of Neurology, University Medical Center Utrecht, Rudolf Magnus Institute for Neuroscience, Utrecht, Netherlands.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.